MASLD may inappropriately exclude lean female NAFLD patients with significant liver fibrosis.
Natsuko KobayashiToshifumi TadaTakashi NishimuraTomomitsu MatonoYukihisa YuriTomoyuki TakashimaNobuhiro AizawaNaoto IkedaShinya FukunishiMariko HashimotoMitsumasa OhyanagiHirayuki EnomotoHiroko IijimaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)
MASLD may inappropriately exclude patients with significant fibrosis, especially lean females with NAFLD. This article is protected by copyright. All rights reserved.